Skip to main content
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. — Investor Relations & Filings

Ticker · RKDA ISIN · US0390142042 LEI · 54930027ZPNA80B8O763 US Agriculture, forestry and fishing
Open in API
Filings indexed 564 across all filing types
Latest filing 2017-01-11 Board/Management Inform…
Country US United States of America
Listing US RKDA

About Arcadia Biosciences, Inc.

https://arcadiabio.com/

Arcadia Biosciences, Inc. is a company focused on developing and marketing plant-based health and wellness products. With a foundation in agricultural innovation, the company cultivates next-generation ingredients and consumer goods. Its primary focus is a portfolio of specialty wheat ingredients designed to offer enhanced nutritional benefits, such as increased fiber, improved protein quality, reduced allergenic gluten, and higher amino acid content. Arcadia aims to transform wheat into a functional food ingredient, collaborating with food manufacturers to create healthier formulations of consumer products. In addition to its wheat ingredients, the company's brand portfolio includes Zola, a line of natural coconut water products.

Recent filings

Filing Released Lang Actions
8-K ANNOUNCING ROGER SALAMEH DEPARTURE
Board/Management Information Classification · 100% confidence The document is a Form 8-K filing with the SEC, dated January 10, 2017, announcing the departure of a senior executive, Roger Salameh, the Chief Operating Officer. The content focuses on the termination of employment and related severance arrangements. There are no financial statements, earnings data, or detailed management discussion. The document is specifically about a change in senior management personnel, which fits the category of Board/Management Information (MANG). The document length is 2523 characters, which is typical for an 8-K announcement of management changes. Therefore, the correct classification is MANG with high confidence.
2017-01-11 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The content specifically announces the departure of a senior officer (Vice President, Chief Legal Officer, and Secretary) effective February 3, 2017, as part of cost reduction efforts. This fits the category of announcements related to changes in the company's board of directors or senior management. The document is not a full annual or quarterly report, nor is it an earnings release or other financial report. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and focused on management change, confirming this classification with high confidence.
2016-12-07 English
8-K ANNOUNCING SHUPP RESIGNATION
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated November 10, 2016. The content specifically announces the resignation of a board member, Darby Shupp, and changes in board roles such as the appointment of an interim chairman and a new audit committee chair. There is no financial data or report attached, nor is it an announcement of a report publication. The primary focus is on changes in the company's board of directors and senior management. According to the filing definitions, this fits the category 'Board/Management Information' (MANG). The document length is short (2640 characters), consistent with a typical 8-K announcement of management changes rather than a full report.
2016-11-15 English
10-Q
Interim / Quarterly Report 9M 2016
2016-11-10 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 10, 2016. It announces the issuance of a press release containing the third quarter 2016 financial results for Arcadia Biosciences, Inc. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release as an exhibit. The length of the document is 3060 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the 'Menu vs Meal' rule, this is an announcement of financial results, not the full earnings release itself. Therefore, the appropriate classification is Earnings Release (ER), as the document announces quarterly financial results and includes a press release with key highlights.
2016-11-10 English
8-K ANNOUNCING VIC KNAUF REITREMENT
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated November 3, 2016. The content announces the retirement of the Chief Scientific Officer, Vic C. Knauf, effective December 31, 2016, and describes management changes related to this departure. There are no financial statements or detailed financial data present. The document focuses on changes in senior management and board-related information. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS. Therefore, the correct classification is MANG with high confidence.
2016-11-09 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.